104 results
S-8
EX-5.1
MIRM
Mirum Pharmaceuticals Inc
15 Mar 24
Registration of securities for employees
5:32pm
speaks only as to law and facts in effect or existing as of the date hereof and we have no obligation or responsibility to update or supplement
8-K
84ee3blp4skyy9
16 Jan 24
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.2
vd3g keutuys
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
S-8
EX-5.1
48nl23en
2 Nov 23
Registration of securities for employees
5:03pm
424B5
dum8g97lf9abcue7m
2 Nov 23
Prospectus supplement for primary offering
4:59pm
S-3ASR
mwr4yikdd2almxpne6m
13 Oct 23
Automatic shelf registration
4:47pm
S-3ASR
EX-5.1
3riynsh gk8co
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
jnt55tysgtfrcigsxmk
13 Oct 23
Other Events
4:16pm
8-K
EX-10.1
dypl0 kvx73w
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-2.1
avq3l oxizu
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.2
5haqgydhqvit
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am